Roper Slumps 1.42% on $350M Volume, 313th in Liquidity Ranking as Sector Pressures Bite

. 15, 2025, , ranking 313th among U.S.-listed stocks by liquidity. The decline came amid a broader market pullback, though ROP’s performance lagged key benchmarks due to sector-specific pressures.

Analysts highlighted muted demand in the company’s core industrial and healthcare segments, with recent earnings reports underscoring margin compression challenges. Institutional selling activity intensified midweek, . The stock’s underperformance contrasted with peers in the S&P 1500, .

To confirm back-test parameters for a 500-stock portfolio strategy, please clarify the following: 1) Should screening include all U.S. equities or a defined universe? 2) Are trades executed at daily close prices or next-day opens? 3) Will weighting be equal across holdings or volume/cap-based? 4) For multi-ticker testing, should we aggregate into an equal-weight synthetic index? Your guidance will ensure alignment with your intended methodology.